Cargando…

MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation

BACKGROUND: Hepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of do...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yinghui, Ye, Mingliang, Wang, Fan, Fang, Jun, Wang, Chun, Luo, Jie, Liu, Jialiang, Liu, Jing, Liu, Lan, Zhao, Qiu, Chang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982593/
https://www.ncbi.nlm.nih.gov/pubmed/33763375
http://dx.doi.org/10.3389/fonc.2021.642030
_version_ 1783667752644378624
author Hong, Yinghui
Ye, Mingliang
Wang, Fan
Fang, Jun
Wang, Chun
Luo, Jie
Liu, Jialiang
Liu, Jing
Liu, Lan
Zhao, Qiu
Chang, Ying
author_facet Hong, Yinghui
Ye, Mingliang
Wang, Fan
Fang, Jun
Wang, Chun
Luo, Jie
Liu, Jialiang
Liu, Jing
Liu, Lan
Zhao, Qiu
Chang, Ying
author_sort Hong, Yinghui
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression. AIMS: Here, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis. METHODS: MiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance. RESULTS: MiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC. CONCLUSION: MiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC.
format Online
Article
Text
id pubmed-7982593
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79825932021-03-23 MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation Hong, Yinghui Ye, Mingliang Wang, Fan Fang, Jun Wang, Chun Luo, Jie Liu, Jialiang Liu, Jing Liu, Lan Zhao, Qiu Chang, Ying Front Oncol Oncology BACKGROUND: Hepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression. AIMS: Here, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis. METHODS: MiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance. RESULTS: MiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC. CONCLUSION: MiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC. Frontiers Media S.A. 2021-03-08 /pmc/articles/PMC7982593/ /pubmed/33763375 http://dx.doi.org/10.3389/fonc.2021.642030 Text en Copyright © 2021 Hong, Ye, Wang, Fang, Wang, Luo, Liu, Liu, Liu, Zhao and Chang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Hong, Yinghui
Ye, Mingliang
Wang, Fan
Fang, Jun
Wang, Chun
Luo, Jie
Liu, Jialiang
Liu, Jing
Liu, Lan
Zhao, Qiu
Chang, Ying
MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_full MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_fullStr MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_full_unstemmed MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_short MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
title_sort mir-21-3p promotes hepatocellular carcinoma progression via smad7/yap1 regulation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982593/
https://www.ncbi.nlm.nih.gov/pubmed/33763375
http://dx.doi.org/10.3389/fonc.2021.642030
work_keys_str_mv AT hongyinghui mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT yemingliang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT wangfan mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT fangjun mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT wangchun mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT luojie mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT liujialiang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT liujing mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT liulan mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT zhaoqiu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation
AT changying mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation